Article
A new physician-owned malpractice insurer
FDA approves Zepbound as first ever prescription drug to treat sleep apnea with obesity
Ep 45: Vaccine hesitancy with Jay W. Lee, MD, MPH, FAAFP
U.S. life expectancy jumped last year; FDA approves first mesenchymal stromal cell therapy to treat SR-aGVHD in pediatric patients; popular vitamins won’t prevent falls or fractures in older adults – Morning Medical Update
Ep 44: Noncompete clauses with Emma Schuering, JD
Great expectations may need adjusting
Mastering the shift to value-based care: 3 strategies for organization-wide success
